HIV-1 upregulates VEGF in podocytes

被引:64
作者
Korgaonkar, Sonal Navin [1 ]
Feng, Xiaobei [5 ]
Ross, Michael D. [1 ]
Lu, Ting-Chi [1 ,3 ]
D'Agati, Vivette [4 ]
Iyengar, Ravi [2 ]
Klotman, Paul E. [1 ]
He, John Cijiang [1 ,3 ]
机构
[1] Mt Sinai Sch Med, Dept Med, New York, NY USA
[2] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY USA
[3] James J Peters VA Med Ctr, Bronx, NY USA
[4] Columbia Univ, Dept Pathol, New York, NY USA
[5] Ruijin Hosp, Dept Nephrol, Shanghai, Peoples R China
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2008年 / 19卷 / 05期
关键词
D O I
10.1681/ASN.2007050629
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
HIV-associated nephropathy (HIVAN) is characterized by collapsing FSGS. Because transgenic mice with podocyte-specific overexpression of the vascular endothelial growth factor 164 (VEGF(164)) isoform also develop collapsing FSGS, we sought to determine whether VEGF plays a role in HIVAN. Compared with controls, immunohistochemistry revealed that kidneys from HIV-1-transgenic mice (Tg26) and from patients with HIVAN had greater expression of both VEGF and its transcriptional regulator, hypoxia-inducible factor 2 alpha (HIF-2 alpha). Similarly, mRNA and protein levels of VEGF and HIF-2a were increased in HIV-infected podocytes in vitro, and this transcriptional upregulation was found to be stimulated by the HIV viral protein Nef in a Src kinase- and Stat3-dependent manner. HIV-1 also upregulated VEGFR2 and its co-receptor neuropilin-1 and suppressed the expression of semaphorin 3a in the podocyte. Exogenous VEGF stimulated proliferation and de-differentiation of podocytes, which are features of collapsing FSGS, and VEGFR2 neutralizing antibodies reversed these features in podocytes infected with HIV-1 or isolated from Tg26 mice. In conclusion, HIV-1 induces VEGF and VEGFR2 expression in podocytes, and this may be a critical step in the pathogenesis of HIVAN.
引用
收藏
页码:877 / 883
页数:7
相关论文
共 30 条
[1]  
Bachelder RE, 2001, CANCER RES, V61, P5736
[2]  
Barisoni L, 1999, J AM SOC NEPHROL, V10, P51
[3]   Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor [J].
Chuang, P. Y. ;
Yu, Q. ;
Fang, W. ;
Uribarri, J. ;
He, J. C. .
KIDNEY INTERNATIONAL, 2007, 72 (08) :965-976
[4]   Differentiated human podocytes endogenously express an inhibitory isoform of vascular endothelial growth factor (VEGF165b) mRNA and protein [J].
Cui, TG ;
Foster, RR ;
Saleem, M ;
Mathieson, PW ;
Gillatt, DA ;
Bates, DO ;
Harper, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 286 (04) :F767-F773
[5]   Loss of the tumor suppressor Vhlh leads to upregulation of Cxcr4 and rapidly progressive glomerulonephritis in mice [J].
Ding, Mei ;
Cui, Shiying ;
Li, Chengjin ;
Jothy, Serge ;
Haase, Volker ;
Steer, Brent M. ;
Marsden, Philip A. ;
Pippin, Jeffrey ;
Shankland, Stuart ;
Rastaldi, Maria Pia ;
Cohen, Clemens D. ;
Kretzler, Matthias ;
Quaggin, Susan E. .
NATURE MEDICINE, 2006, 12 (09) :1081-1087
[6]   Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases [J].
Eremina, V ;
Sood, M ;
Haigh, J ;
Nagy, A ;
Lajoie, G ;
Ferrara, N ;
Gerber, HP ;
Kikkawa, Y ;
Miner, JH ;
Quaggin, SE .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (05) :707-716
[7]   The biology of VEGF and its receptors [J].
Ferrara, N ;
Gerber, HP ;
LeCouter, J .
NATURE MEDICINE, 2003, 9 (06) :669-676
[8]   Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes [J].
Foster, RR ;
Hole, R ;
Anderson, K ;
Satchell, SC ;
Coward, RJ ;
Mathieson, PW ;
Gillatt, DA ;
Saleem, MA ;
Bates, DO ;
Harper, SJ .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 284 (06) :F1263-F1273
[9]  
Fuh G, 2000, J BIOL CHEM, V275, P26690
[10]   VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism [J].
Gerber, HP ;
Malik, AK ;
Solar, GP ;
Sherman, D ;
Liang, XH ;
Meng, G ;
Hong, K ;
Marsters, JC ;
Ferrara, N .
NATURE, 2002, 417 (6892) :954-958